Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 13Phase 1/2 11Phase 3 5

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 1Genitourinary 1

Conditions

Breast Neoplasms 3Neoplasms 2Triple Negative Breast Neoplasms 1Skin Diseases 1Prostatic Neoplasms 1Neoplasms by Site 1Breast Diseases 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Interventional × ipatasertib × Clear all
NCT05862285 2026-05-12

UmbrellaMAX

Hoffmann-La Roche

Phase 3 Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04650581 2026-04-13

FINER

Canadian Cancer Trials Group

Phase 3 Active not recruiting
250 enrolled 13 charts
Breast

Breast Neoplasms

NCT03072238 2025-06-06

IPATential150

Hoffmann-La Roche

Phase 3 Completed
1,101 enrolled 35 charts
Genitourinary

Prostatic Neoplasms

NCT04177108 2024-03-27

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Hoffmann-La Roche

Phase 3 Completed
242 enrolled 12 charts
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases, Triple Negative Breast Neoplasms

NCT03337724 2024-03-12

IPATunity130

Hoffmann-La Roche

Phase 3 Completed
579 enrolled 33 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡